|

Testing the Effects of a Text Message Caregiver Support Intervention for Latinos

RECRUITINGN/ASponsored by University of Kansas Medical Center
Actively Recruiting
PhaseN/A
SponsorUniversity of Kansas Medical Center
Started2025-02-17
Est. completion2029-05
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
Locations1 site

Summary

The goal of this randomized clinical trial it to test the efficacy of CuidaTEXT, the first Alzheimer's disease and Related Dementias (ADRD) caregiver support intervention to capitalize on text messaging, among Latinos. Researchers will compare those who receive the CuidaTEXT intervention to those who do not receive the intervention to see if CuidaTEXT effects Latino caregiver stressors and their negative consequences . Participants will receive a variety of text messages, from automatic to keyword-drive, regarding ADRD education, social support, self-care, ADRD care management, and behavioral symptoms. Participants will also complete measures regarding depressive symptoms, coping, behavioral symptoms, and preparedness for caregiving.

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* Over the age of 18
* Spanish and English-speaking people who identify as Latino
* Reports providing hands-on care for a relative who has been given a clinical or research ADRD diagnosis and has an Eight-item Informant Interview to Differentiate Aging and Dementia (AD-8) screening score ≥2, indicating cognitive impairment
* Has a score of 7 or higher on the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10)
* Self-reports being able to read and write
* Owns a cell phone with a flat fee, and uses it at least weekly for texting.

Exclusion Criteria:

* Participation in another wellbeing-related clinical trial
* Cohabitation with another participant in the CuidaTEXT R01 Study
* Participants who provide care for a person with ADRD already cared for by another participant in the CuidaTEXT R01 study
* Participant plans to move to another country within seven months

Conditions2

Alzheimer DiseaseAlzheimer's Disease

Locations1 site

University of Kansas Medical Center
Fairway, Kansas, 66205
Rachel Ruiz913-945-5052rruiz3@kumc.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.